Target |
Target Cell |
DMARD |
Main
Result(s) |
Reference |
ROS1 |
Jurkat T-
cells, EL4
Thymoma,
Raji B cells |
MTX |
↓ proliferation;
↑ Apoptosis;
↑ROS |
167 |
ICAM-12 CLA3 |
T-cells |
MTX |
↓ ICAM-1,
CLA;
↓ T-cell
activation |
168 |
CD11b, CD64,CD86,CD69 |
VERA4
Neutrophils |
MTX |
Restoration of
delayed
apoptosis |
169 |
Dihydroorotic
dehydrogenase |
Mast cells |
Leflunomide |
↓ p-AKT5
↓ PDK-1
↑ Apoptosis |
170 |
Caspase-3 |
RA-FLS |
Celecoxib |
↔6 Caspase-3; ↔ Apoptosis |
171 |
NF-κB
Caspases
|
1° Mφ7,
RAW264.7
Cells
Jurkat T-
cells, THP-18 |
MTX
Infliximab |
↑ Apoptosis in
1°Mφ;
TNF-α suppressed MTX-induced apoptosis
↑ Apoptosis9;
↑ Caspase
activity9
↓ IL-109
↓ IL-129 |
172
173 |
1Reactive oxygen species
2Intercellular adhesion molecule-1
3Cutaneous lymphocyte-associated antigen
4Very early rheumatoid arthritis patients
5phosphorylated-AKT
6No change
7Primary macrophages
8THP-1 is a human monocyte cell line
9Ex vivomeasurements from cells recovered from human-mouse chimera treated with infliximab |